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Abstract
Inflammation promotes granulopoiesis over B lymphopoiesis in the bone marrow (BM). We studied B cell homeostasis in
two murine models of T cell mediated chronic inflammation, namely calreticulin-deficient fetal liver chimeras (FLC), which
develop severe blepharitis and alopecia due to T cell hyper responsiveness, and inflammatory bowel disease (IBD) caused by
injection of CD4+ naı¨ve T cells into lymphopenic mice. We show herein that despite the severe depletion of B cell
progenitors during chronic, peripheral T cell-mediated inflammation, the population of BM mature recirculating B cells is
unaffected. These B cells are poised to differentiate to plasma cells in response to blood borne pathogens, in an analogous
fashion to non-recirculating marginal zone (MZ) B cells in the spleen. MZ B cells nevertheless differentiate more efficiently to
plasma cells upon polyclonal stimulation by Toll-like receptor (TLR) ligands, and are depleted during chronic T cell mediated
inflammation in vivo. The preservation of mature B cells in the BM is associated with increased concentration of
macrophage migration inhibitory factor (MIF) in serum and BM plasma. MIF produced by perivascular dendritic cells (DC) in
the BM provides a crucial survival signal for recirculating B cells, and mice treated with a MIF inhibitor during inflammation
showed significantly reduced mature B cells in the BM. These data indicate that MIF secretion by perivascular DC may
promote the survival of the recirculating B cell pool to ensure responsiveness to blood borne microbes despite loss of the
MZ B cell pool that accompanies depressed lymphopoiesis during inflammation.
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Introduction
An ordered sequence of phenotypes characterizes B cell
development in the BM from the common lymphoid progenitor
(CLP) (Lin2c-KitloIL-7R+) [1]. Rearrangement of the IgH locus
determines the expression of the pre-B cell receptor (pre-BCR) and
the transition of pro-B cells to the pre-B cell (B220loCD2+) stage
[2]. The progression to the following immature B cell stage
(B220+IgM+IgDlo) is characterized by expression of the BCR.
Immature B cells leave the BM and develop into mature follicular
(FO) B cells (IgM+/loIgD+) in the spleen. These cells recirculate
and home to B cell areas in secondary lymphoid organs where they
mediate T-dependent humoral immune responses. A distinct non-
recirculating mature population in the spleen is constituted by MZ
B cells (IgMhiIgDlo), which line the marginal sinus and respond to
blood-borne antigens. Together with peritoneal and mucosal B-1
B cells MZ B cells provide T-independent immune responsiveness
to multivalent antigens and generate the natural antibody
repertoire [3]. Recently, a subset of recirculating mature B cells
was shown to occupy a perisinusoidal niche in the BM and to be
activated by blood-borne pathogens in a T cell-independent
fashion to generate specific IgM responses, analogously to MZ B
cells [4].
The increased peripheral demand of granulocytes during an
infection or inflammatory condition promotes granulopoiesis over
B lymphopoiesis in the BM [5,6]. The consequences of
inflammation on B cell subsets representation have not been
investigated to date. We used two murine models of T cell
mediated chronic inflammation to address this issue. Calreticulin-
deficient (crt2/2) T cells display an altered regulation of calcium
signalling upon TCR stimulation, which results in protracted
nuclear translocation of nuclear factor of activated T cell (NFAT)
and activation of the mitogen activated protein kinase (MAPK)
pathway. This results in lower threshold of T cell activation and
hyper responsiveness upon antigen encounter. Adoptive transfer of
crt2/2 fetal liver progenitors into recombinase-deficient mice to
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reconstitute the lymphoid system determines a T cell dependent
inflammatory disease characterized by severe blepharitis and
alopecia [7]. As a second model of chronic inflammation we used
cd3e2/2 mice in which we induced IBD by transfer of naı¨ve CD4+
T cells [8]. We demonstrate that chronic inflammation results in
MZ but not BM mature B cells depletion. MIF, which constitutes a
crucial survival signal for BM mature B cells [9], was increased
during inflammation. Pharmacological inhibition of MIF deter-
mined reduction of BM mature B cells, thereby suggesting a
function for MIF in ensuring blood borne antigens responsiveness
upon depletion of MZ B cells.
Results
Altered BM myeloid and lymphoid lineage
representation in mice with T cell mediated inflammation
Crt2/2 T cells have an altered regulation of calcium signalling
resulting in hyper responsiveness to TCR stimulation. In crt2/2
FLC, this altered signalling results in a severe T cell mediated
immunopathological condition starting at week 8 after reconsti-
tution and characterized by blepharitis, alopecia and wasting
syndrome [7]. The skin from these animals is characterized by
inflammatory granulocytes mainly localized in superficial derma
with focal infiltration of epidermis (Fig. 1a). In the BM, the
myelo-erythroid ratio was altered by the presence of striking
myeloid hyperplasia with left-shifted maturation (Fig. 1b). No
differences in cell recovery from BM of both crt2/2 and crt+/+
FLC were detected, however, FACS analysis with specific lineage
markers of the lymphoid, myeloid and erythroid compartment
showed a significant increase in CD11b+Gr1lo cells (promyelo-
cytes/myelocytes), CD11b+Gr1hi cells (metamyelocytes/granulo-
cytes) [10], and CD11bloGr1lo cells (mainly monocytes). Of note,
we observed a decrease in B lymphoid (B220+) and erythroid
(Ter119+) elements (Fig. 1c). Concomitantly, the increased
granulopoiesis was correlated to the increase in both immature
and mature granulocytes in the spleen of crt2/2 FLC (Fig. 1d).
These alterations were not observed in crt2/2/cd3e2/2 double
knock-out (KO) FLC, which do not develop inflammatory
manifestations because of the absence of pathogenic T cells
(Figure S1).
Figure 1. Histopathology and enhanced granulopoiesis in crt2/2 FLC. (A) H&E stained sections show dermal granulocytic inflammatory
infiltrate in the skin of crt2/2 FLC at week 12 post-transplant, as opposed to crt+/+ FLC, where inflammatory cells are absent (bar = 50 mm in left panels;
bar = 10 mm in right panels). (B) Bone marrow sections of crt2/2 FLC reveal a pronounced increase in myeloid precursors with left-shifted maturation
and marked reduction of red cell precursors; crt+/+ FLC retain the physiological myelo-erythroid ratio (original magnification, 636). (C) Bone marrow
cellularity with relative representations of B220+ (crt+/+, n = 35, crt2/2, n = 39) and Ter119+ (crt+/+, n = 8, crt2/2, n = 5) cells (top) at weeks 12–18 after
reconstitution; dot plot analysis of BM cells stained with CD11b and Gr-1 antibodies and histograms with distribution of the indicated subsets (crt+/+,
n = 16, crt2/2, n = 10). (D) Dot plot analysis of splenocytes stained with CD11b and Gr-1 antibodies and histograms with distribution of the indicated
subsets (crt+/+, n = 11, crt2/2, n = 9). White bars: crt+/+ FLC; black bars: crt2/2 FLC.
doi:10.1371/journal.pone.0011262.g001
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Depletion of early stages of B cell development but not
BM mature B cell compartment during inflammation
To better define the B220+ cell defect with respect to B cell
development in crt2/2 FLC we first enumerated pre-B cells
(B220loCD2+) [2] (.98% CD19+) and immature B cells
(B220+IgM+IgDlo). These analyses revealed a significant decrease of
both cell subsets in crt2/2 FLC (Fig. 2). Additional staining with
CD43 and IgM antibodies showed the severe reduction of pre-B cells
(Figure S2). Furthermore, we detected a dramatic depletion of CLP
defined as lineage-negative c-kitlo, IL-7R+ cells (manuscript in
preparation). In contrast, the relative representation, but not absolute
number, of the mature B cell compartment (B220+IgMlo/+IgD+)
was significantly increased (Fig. 2c).
To determine if the crt2/2 B cell progenitors had an intrinsic
functional impairment due to deletion of the crt gene, we evaluated
the proliferative response of sorted B220loCD43lo/+IgM2 cells
comprising pro- and pre-B cells to IL-7 in vitro. Committed B cell
precursors are known to depend on IL-7 for survival and expansion
[11,12]. Bone marrow samples were collected at week 4 and 5 after
reconstitution, at which time mature T cells were not detected in the
periphery and there were no signs of immunopathology in the crt2/2
FLC. Similar percentages of pre-B cells defined by B220 and CD2
staining were observed in both crt2/2 and crt+/+ FLC at this time
(crt2/2: 10.562.1; crt+/+: 9.760.9; n=5), and other B cell
developmental stages were not found to differ between these two
mouse strains. Comparable 3H-thymidine incorporation by sorted
B220loCD43lo/+IgM2 crt2/2 and crt+/+ cells upon exposure to
decreasing concentrations of IL-7 also was observed (Fig. 2b),
indicating that crt deletion did not affect the expansion potential of
early B cell progenitors. Moreover, in T cell depleted crt2/2/cd3e2/2
double KO FLC that did not develop inflammation, the represen-
tations of the pre-, immature and mature B cell stages were
indistinguishable in crt+/+/cd3e2/2 and crt2/2/cd3e2/2 FLC (Figure
S1b,c). These data demonstrate that crt deletion in hematopoietic
progenitors did not alter their B lymphopoietic potential.
To substantiate the alterations observed in crt2/2 FLC as a
general consequence of T cell mediated tissue inflammation, we
used a murine model of IBD. We induced the disease by
transferring CD4 T cells in the absence of the CD25+ T regulatory
(Treg) subset into lymphopenic hosts. Indeed, a failure in the
induction of regulatory T cell responses by gut microflora has been
shown to cause severe mucosal inflammation by effector T cells
Figure 2. B cell progenitors but not mature B cells depletion in the BM of crt2/2 FLC. (A) Dot plot analysis of BM cells from FLC stained with
B220 and CD2 antibodies. The gate corresponding to pre-B cells used for the statistical analysis (below) is indicated. (B) 3H-thymidine incorporation to
serial dilutions of recombinant IL-7 by sorted BM pro- and pre-B cells (see Results). (C) Dot plot analysis of electronically gated B220+ cells stained with
IgM and IgD antibodies with statistical analysis of the respective subsets (below). Mice were analysed at weeks 12–18 after reconstitution.
doi:10.1371/journal.pone.0011262.g002
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that overproduce proinflammatory cytokines [8]. Naive CD4 T
cells isolated from C57BL/6 mice were sorted as
CD4+CD442CD252CD62L+ cells and injected into syngeneic
cd3e2/2 mice. As a control, we used mice injected with sorted
CD4 naı¨ve cells together with sorted CD4+CD25+ cells [13] (see
Methods). Mice were sacrificed at week 5 after cell transfer and
IBD was assessed by weight loss (IBD mice: 15.560.9 g, n= 5;
Control mice: 20.761.0 g, n= 5, P=0.0001) and histological
examination of the colon. As observed in crt2/2 FLC, B220+ and
Ter-119+ cells were significantly decreased whereas granulocytes
and monocytes as well as their progenitors were significantly
increased (Fig. 3a). The B220+ cells depletion was more dramatic
than in crt2/2 FLC, analogously to crt2/2 FLC selectively affected
pre- and immature B cells, whereas the percentage of mature B
cells was significantly increased (Fig. 3b). These results demon-
strate that depletion of the immature B cell pool and the relative
preservation of BM mature B cells is a common feature of T cell
mediated inflammation.
Transcriptional regulation of CXCL12, SCF and IL-7 upon
peripheral tissue inflammation
CXCL12 is released from BM stromal cells and is involved in
retention of early B cell precursors within the BM microenviron-
ment [14]. CXCL12 and SCF transcripts were downregulated in
the BM upon immunization with incomplete Freund adjuvant
(IFA), and this effect was correlated to the transient reduction of B
cell progenitors [10]. We performed real-time PCR to quantify
CXCL12, SCF, and IL-7 transcripts in crt2/2 FLCs at different
times after reconstitution. Kinetic analysis of these transcripts in
crt2/2 and crt+/+ FLCs revealed the significant reduction of both
CXCL12 and SCF, and the reduction of IL-7, albeit not to
significance (Fig. 4b) in crt2/2 FLC. This reduction in cytokine
expression occurred concomitantly with progressing inflammation,
as measured by the increase in lymph nodes effector/memory T
cells (Fig. 4a). These results suggest that downregulation of both
CXCL12, SCF and IL-7 could contribute to the reduction of B
cell progenitors in the BM of mice during chronic inflammation.
Accordingly, we detected significantly increased numbers of
CD93highB220lowIgM2 B cell progenitors in the spleen of mice
with IBD with respect to healthy controls (Controls:
0.22610660.04, n= 5; IBD: 1.76610661.17, n = 5, P=0.039).
Depletion of marginal zone B cells in the spleen of crt2/2
FLC and mice with IBD
Spleen cellularity was increased in chronic inflammation but the
percentage of B220+ cells was significantly reduced. Mature FO B
cells (IgMlo/+IgD+) were not significantly altered, whereas
transitional B cells [15] were significantly diminished in both
crt2/2 FLC and mice with IBD (Fig. 5a,b), in line with a reduced
BM output of immature B cells. To evaluate the impact of chronic
inflammation on marginal zone B cells representation, we stained
splenocytes from crt2/2 FLC and mice with IBD with B220
together with CD21 and CD23 specific antibodies. Figure 5c
shows the significant reduction of CD21high CD23lo MZ B cells
[16] in both inflammatory conditions.
Transcriptional profiles of mature B cell subsets and
responsiveness to TLR9 ligand
The transcription of TLRs differs quantitatively but not
qualitatively in FO and MZ B cells [17]. The analysis of MZ
versus BM mature B cells in three different experiments revealed
increases, albeit not reaching statistical significance, in TLR7 and
9 transcripts, whereas TLR3 was exclusively expressed in MZ B
cells. Figure 6a shows results obtained in one representative
experiment. In vitro stimulation of purified FO, MZ and BM
mature B cells with TLR9 ligand CpG 1826 revealed the more
efficient transition of MZ B cells to Ig secreting cells (ISCs), as
measured by CD138 expression (Fig. 6c) and Ig secretion (Fig. 6d).
Transcriptional regulation of Pax5, Bcl-6, Blimp-1 and XBP-1
controls differentiation of B cells to plasma cells. Reciprocal
expression of Bcl-6 and Blimp-1 ensures the differential fate of
activated B cells either to enter the germinal center or differentiate
into ISC, respectively [18]. In resting conditions mature BM B
cells displayed low levels of Bcl-6 and Pax-5 transcripts, similar to
Figure 3. Erythroid, myeloid and B cell subsets in BM from IBD. (A) Bone marrow cellularity, percentages of Ter119+ cells and myelocytes
subsets by CD11b and Gr-1 expression (see fig. 1 legend) in BM of mice with IBD, n = 5. (B) Statistical analysis of B cell subsets representation in BM of
mice with IBD, n = 5. White bars: healthy; black bars: IBD. Mice were analysed 4 weeks after transfer of CD4+ cells.
doi:10.1371/journal.pone.0011262.g003
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MZ B cells. In contrast, FO B cells displayed high levels of Bcl-6
and Pax-5 transcripts. After CpG stimulation however, mature
BM B cells displayed less robust upregulation of Blimp-1 and
XBP-1, similarly to FO B cells (Fig. 6b). In spite of some different
Pax-5 transcript levels in MZ versus FO B cells observed by
Genestier et al. [17], analogous downregulation of Pax-5 in MZ B
cells upon TLR9 stimulation was observed. These results suggest
that MZ B cells differentiate more readily into plasma cells by
Figure 4. Kinetics of peripheral effector/memory T cells and transcripts in BM from FLC. (A) Percentages of peripheral CD4 effector/
memory T cells in lymph nodes measured at different times following reconstitution of RAG/c chain DKO mice with crt+/+ and crt2/2 fetal liver
progenitors (mean 6 SD of at least 5 mice). Black line, crt+/+; red line, crt2/2; *** = P,0.001. (B) Quantification by real time PCR of SCF, CXCL12, IL-7
and HPRT transcripts in BM at different time points after reconstitution (mean 6 SD of at least 3 samples), ** = P,0.01 and * = P,0.05.
doi:10.1371/journal.pone.0011262.g004
Figure 5. Depletion of MZ B cells in inflammation. (A) Dot plot analysis of electronically gated B220+ splenocytes stained with IgM and IgD
specific antibodies in representative crt+/+ and crt2/2 FLC. Spleen cellularity, relative representation of B220+ cells, absolute numbers of mature FO B
cells (IgD+IgMlo/+ gate in the dot plot) and transitional B cells (IgDdullIgM+ gate in the dot plot) in spleens from crt+/+ (n = 35) and crt2/2 (n = 31) FLC at
weeks 12–18 after reconstitution. (B) The same analysis was performed on splenocytes from healthy mice (ctrl, n = 5) or mice with IBD (IBD, n = 5) 4
weeks after adoptive cell transfer. (C) Representative dot plots on B220+ cells with MZ B cells gate (left graphs), statistical analyses of absolute
numbers of MZ B cells in crt+/+ and crt2/2 FLC at weeks 12–18 after transplant (crt+/+, n = 24, crt2/2, n = 30) (middle graph) and healthy mice (ctrl,
n = 5) or mice with IBD (IBD, n = 5) 4 weeks after adoptive cell transfer (right graph).
doi:10.1371/journal.pone.0011262.g005
B Cells in Inflammation
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stimulation with TLR ligands generated by tissue damage during
T cell mediated inflammation, thereby leading to their exhaustion
in concomitance with depressed B lymphopoiesis.
Role of macrophage migration inhibitory factor (MIF) in
the preservation of BM mature B cell pool upon
peripheral tissue inflammation
Recently, MIF produced by BM perivascular dendritic cells was
shown to be crucially involved in the survival of BMmature B cells [9].
We measured serum and BM plasma levels of MIF at week 12 after
reconstitution in crt+/+ and crt2/2 FLC. Significant increases in MIF
concentrations were detected in both serum and BM plasma from
crt2/2 FLC (Fig. 7a), thus suggesting that increased MIF secretion
might ensure the maintenance of the BM mature B cell pool during
inflammation. Analogously, mice with IBD displayed increased serum
levels of MIF with respect to healthy controls (Fig. 7b).
To establish a causal relationship between increased MIF and
BM mature B cells preservation during inflammation, we treated
mice with IBD for six days by intravenous administration of ISO-
1. ISO-1 is a non-toxic inhibitor of MIF that binds to bioactive
MIF at a catalitically active tautomerase site [19,20]. This
treatment did not modify the representation of F4/80+CD103+
perivascular DC identified by staining with CD11c and MHC
class II specific antibodies. However, mature B cells were
significantly reduced in treated mice (Fig. 7c, Figure S3), indicating
that MIF was mediating the preservation of BM mature B cell pool
during chronic inflammation.
Discussion
Newly developed B cells migrate from the BM to the spleen
where they primarily mature into recirculating FO B cells and also
differentiate into non recirculating MZ B cells, which are
Figure 6. TLRs expression and response of BM mature, FO and MZ B cells to CpG 1826. (A) Representative experiment showing TLRs
expression by quantitative real-time PCR on sorted resting B cell subsets. AU: arbitrary unit. Mean values of triplicates 6 SD from a single experiment
are shown. (B) Expression of Bcl6, Blimp-1, Pax-5 and XBP-1 transcription factors by real-time PCR on the indicated B cell subsets either non stimulated
(black bars) or after 48 h of stimulation with CpG at 100 nM (white bars). AU: arbitrary unit. Mean values of duplicates 6 SD from a single experiment
are shown. (C) Percentages of CD138+ B cells after 4 day stimulation of the indicated B cell subsets with CpG 1826 at 100 nM. (D) IgM secretion by the
indicated B cell subsets after 4 day stimulation with CpG 1826 at different doses.
doi:10.1371/journal.pone.0011262.g006
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strategically located to respond to blood-borne pathogens in a T-
independent fashion [3]. Recently, mature B cells residing in a
perivascular niche in the BM also were characterized as responsive
to blood-borne pathogens in a T-independent fashion, analogously
to MZ B cells [4]. Chronic inflammation with severe tissue
damage skews hematopoiesis toward the granulocyte/monocyte
lineage with concomitant reduction of erythroid Ter-119+ cells
and depression of B lymphopoiesis. Both megacaryocyte/erythro-
cyte progenitors (MEPs) and common lymphoid progenitors
(CLPs) were significantly reduced in both crt2/2 FLCs and mice
with IBD, whereas granulocyte/monocyte progenitors (GMPs)
were significantly increased (manuscript in preparation). In
addition, we detected immature B cell progenitors in the spleen
of mice with IBD concomitantly with downregulation of CXCL12,
as observed in acute inflammation [6]. Our study revealed that
inflammatory tissue damage affects the MZ B cell population.
Inflammation might represent a chronic source of TLR agonism
and it has been noted that TLR agonists promote differentiation to
ISC of MZ but not FO B cells. This might explain the preferential
depletion of the former B cell population during chronic
inflammation, in an analogous fashion to what observed during
infection with different T-independent pathogens [21,22]. Mature
BM B cells share transcriptional profiles with MZ B cells and
differentiate into Ig secreting cells by stimulation with TLR
agonists, albeit with an efficiency comparable to FO rather than
MZ B cells. Both BM mature and MZ B cells have a long half-life
[23], however the reduced TLR responsiveness and the recircu-
lating nature of the BM mature B cell pool with possible
replenishment by selection from the FO B cell pool may explain
the differential sensitivity of these two B cell compartments to
chronic tissue damage.
Since a minor fraction of mature B cells differentiate in the BM
from transitional B cells without any requirement for the spleen or
other secondary lymphoid organs [24], it is also possible that the
perisinusoidal niche where this compartment homes to is less
affected by increased granulopoiesis. Some measure of B cell
development thus may continue to take place at this site. A
topographical analysis of B cell distribution in the rat BM has
shown that pre-B but not mature B cells were selectively enriched
in the subendosteal area [25]. Ueda et al. has suggested that
granulopoiesis and lymphopoiesis share the same developmental
niche and compete for the same developmental resources [10].
The sparing of the B cell developmental potential of the
perisinusoidal niche would ensure ‘‘emergency’’ B lymphopoiesis
and protection against blood-borne pathogens during inflamma-
tory tissue damage.
A subset of bone marrow-resident dendritic cells organized in
perivascular clusters was shown to provide crucial survival signals
for mature recirculating B cells through the production of MIF [9].
Indeed, MIF was shown to induce B cell survival by activation of
the CD74-CD44 receptor complex [26]. Serum and BM plasma
levels of MIF were increased upon T cell mediated inflammation.
We used the specific MIF inhibitor ISO-1 [19] to show that the
selective preservation of the mature BM B cell subset during
experimentally-induced IBD was dependent on MIF biological
activity. Altogether, the data presented in this study allow for a
model whereby T cell mediated inflammation could impact on the
MZ B cell potential to generate T-independent responses against
Figure 7. Increased MIF concentrations in inflammation and selective depletion of BM mature B cells by ISO-1. (A) Serum and BM
plasma concentrations of MIF in FLC. (B) Serum concentrations of MIF in healthy mice (ctrl) or mice with IBD (IBD). (C) Absolute numbers of F4/
80+CD103+ perivascular DC identified as CD11chighMHCIIhigh and percentages of BM mature (IgD+IgMlo/+) cells in gated B220+ cells in healthy mice
(ctrl) or mice with IBD either mock treated (IBD) or treated with ISO-1 (IBD/ISO-1).
doi:10.1371/journal.pone.0011262.g007
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blood-borne pathogens. This possible vulnerability is counteracted
by the MIF-mediated preservation of the recirculating mature B
cell pool in the BM, thus ensuring serological responsiveness to
blood-borne microbes.
One possible drawback in the dominant responsiveness to
blood-borne antigens by BM mature, recirculating B cells may
originate from the distinct repertoire of this subset with respect to
MZ B cells. Indeed, the selection of cells lacking N regions and
with shorter CDR3s in the immunoglobulin repertoire of MZ B
cells but not BM mature B cells was hypothesized to confer to MZ
B cells a reduced potential for harmful autoreactivity [27].
Accordingly, TdT deficiency was shown to reduce autoimmune
disease incidence and severity [28,29]. The preferential respon-
siveness of BM recirculating B cells to blood-borne pathogens thus
may impose an autoimmune hazard to the organism during
chronic inflammation.
Materials and Methods
Ethics Statement
Experiments were approved by the ‘‘Dipartimento della Sanita`
e della Socialita`’’ with authorizations 8/2007, 10/2007 and 01/
2009.
Mice
Crt+/2 (H-2b) mice [30], BALB/c RAG/c chain DKO (H-2d)
mice obtained from Dr. Mamoru Ito (Central Institute for
Experimental Animals, Miyamae, Kawasaki, Japan) and cd3e2/2
mice from Jackson Laboratory were bred and treated in
accordance with the Swiss Federal Veterinary Office guidelines.
FLC in RAG/c chain DKO mice with crt+/+ and crt2/2
progenitors were generated as described [7]. Briefly, sublethally
irradiated mice were injected i.v. with 26106 genotyped fetal liver
cells in 200 ml PBS. Similarly, FLC with crt2/2/cd3e2/2 and
crt+/+/cd3e2/2 progenitors were generated by breeding crt+/2/
cd3e2/2 mice.
Histochemistry
The mice were dissected and tissues were immediately fixed in
buffered formalin. A multi-organ microscopic analysis, including
hematopoietic organs, was carried out. Bone marrow was obtained
from femurs, fixed, and decalcified in EDTA-based solution. Each
specimen was paraffin-embedded, cut into 4 mm-thick sections and
stained with Hematoxylin & Eosin (H&E) and Giemsa. Individual
specimens were independently analysed by two of us (M.P and
F.S), without knowledge of mice genotype.
Flow cytometry
For flow cytometry analyses, mAbs conjugated with either
biotin, FITC, PE, CyChrome, PerCP or APC against the
following antigens were used: CD8a (53-6.7), CD4 (L3T4),
CD62L (MEL-14), CD44 (IM7), CD25 (PC61.5), Gr-1 (RB6-
8C5), CD2 (RM2-5), TER-119, CD11b (M1/70), CD19 (6D5),
CD21 (8D9), CD23 (B3B4), CD43 (R2/60), CD49b (DX5) and
MHC class II (M5/114.15.2) (eBioscence); CD45R/B220 (RA3-
6B2), IgM (II/41), IgD (11.26c.2a), and APC-Cy7-streptavidin
(BD Bioscience). All samples were acquired with a FACScalibur or
FACSCanto (Becton Dickinson Immunocytometry Sistems) and
analyzed with FlowJo software (Treestar Inc.).
Pro-, pre-B cell proliferation assay
B cells were isolated from BM by negative selection with
immunomagnetic beads followed by cells sorting. Cell suspensions
were incubated with biotin-conjugated antibodies (Ter119,
panNK, CD11b, Gr-1, CD4 and CD8) (eBioscence) and B cell
enriched by removing biotin-labeled cells with streptavidin
conjugated magnetic beads (Miltenyi Biotec). Pro/pre B
(B220+IgM2CD43+) cells were sorted at FACSAria (Becton
Dickinson), plated at 26104 cells/well, and cultured in presence
of rIL7 in 96 well plates. At day 4 [3H]-thymidine (2 mCi/well) was
added and the plates were harvested after 16 h incubation.
Induction of inflammatory bowel disease
For the induction of IBD, T cells were isolated from the
peripheral lymph nodes and spleen of C57BL/6 mice by negative
selection with immunomagnetic beads followed by cells sorting.
Cell suspensions were incubated with biotin-conjugated antibodies
(Ter119, panNK, CD11b, Gr-1 and CD19) (eBioscence) and T
cells enriched by removing biotin-labeled cells with streptavidin
conjugated magnetic beads (Miltenyi biotec). CD4+ naı¨ve
(CD4+CD442CD252CD62L+) and regulatory (CD4+ CD25+) T
cell subsets were sorted at FACSAria (Becton Dickinson). Cd3e2/2
mice were i.v. injected with 0.46105 CD4+ naı¨ve T cells. As a
control, mice were injected with CD4 naı¨ve cells together with
0.26105 CD4+CD25+ Treg cells. Mice were weighted weekly and
were sacrificed at week 5 after cell transfer, when IBD was
diagnosed by severe diarrhea and weight loss. For ISO-1
(Calbiochem) treatment, mice were injected 4 weeks after cell
transfer for 6 days with 20 mg/kg of ISO-1 intravenously. Control
mice were injected with carrier alone.
Quantification of mRNA levels
mRNA from 0.26106 BM cells was precipitated in Trizol
(Invitrogen) and reverse transcribed (M-MLV, Invitrogen).
Quantitative PCR amplifications of cDNA were performed in an
ABI PRISM 7700 Sequence Detector (PE Applied Biosystem) with
SYBR Green PCR core reagents (Applied Biosystems) and primers
specific for HPRT, GAPDH, SCF, CXCL12 or IL7 transcripts.
The following standard amplification parameters for the quanti-
tative PCR were used: initial denaturation at 94uC for 10 min;
amplification cycle; denaturation at 94uC for 45 s; and anneal/
extension at 64uC for 45 s. The relative gene expression levels
were calculated by the comparative CT (threshold cycle) method
recommended by the manufacturer (Applied Biosystems) normal-
ized to GAPDH message in the same sample, as described [10]. In
brief, DCT values were determined by subtracting CT (GAPDH)
from CT (target). Expression levels relative to GAPDH were defined
as: 22DCT. Expression data were standardized to averaged,
homologous message in crt+/+ BM cells. Levels of a second
housekeeping gene, HPRT, were used as control for nonspecific
changes in message levels. The following primers were used
[10,31]:
HPRT forward 59-GCTGGTGAAAAGGACCTCT-39
reverse 59-CACAGGACTAGAACACCTGC-39
GAPDH forward 59-AACTTTGGCATTGTGGAAGG-39
reverse 59-ACACATTGGGGGTAGGAACA-39
SCF forward 59-CGGGAATCCTGTGACTGATAA-39
reverse 59-GGCCTCTTCGGAGATTCTTT-39
CXCL12 forward 59-GTCCTCTTGCTGTCCAGCTC-39
reverse 59-TAATTTCGGGTCAATGCACA-39
IL-7 forward 59-TGGAATTCCTCCACTGATCC-39
reverse 59-ACCAGTGTTTGTGTGCCTTG-39
TLRs expression and responsiveness of BM mature, FO
and MZ B cells to CpG 1826
TLRs expression was evaluated on sorted, non-stimulated B
cells. B cells were isolated from spleen and BM by positive
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selection with immunomagnetic beads specific for B220 (Miltenyi
Biotec). Then, MZ (B220+CD21highCD23lo), FO (B220+
CD21+CD23+) and BM mature (B220+IgM+IgD+) B cells were
sorted at FACSAria (Beckton Dickinson). For quantitative
assessment of relative mRNA levels, total RNA was prepared
from FACS-sorted population using Trizol LS reagent according
to the manufacturer’s instructions. RNA then was reverse
transcribed using the M-MLV RT reverse transcription kit with
random primers (Invitrogen). The relative mRNA levels were
determined by real-time PCR on an ABI PRISM 7900 HT
sequence detector (Applied Biosystems) using the assay on
demand product for TLRs (TLR1 Mm00441868_s1, TLR2
Mm00442346_m1, TLR3 Mm01207403_m1, TLR4
Mm00445273_m1, TLR5 Mm00546288_s1, TLR6
Mm02529782_s1, TLR7 Mm00446590_m1, TLR8
Mm01157262_m1, TLR9 Mm00446193_m1), Blimp1
(Mm01187285_m1), XBP1 (Mm00457360_g1), Bcl6
(Mm00477635_m1) and Pax5 (Mm01345231_m1).
To analyse B cell responsiveness to CpG 1826, B cell subsets
were stimulated at 36104 cells/well with CpG 1826 at 4, 20 and
100 nM. At day 4, immunoglobulin production was evaluated in
the supernatant with a standard ELISA assay. Briefly, 96 flat
bottom plates (Greiner) were coated with isotype specific goat anti-
mouse IgM antibodies (Southern Biotechnologies) diluted in
Na2HPO4 0,2 M pH 9.6 and incubated overnight at 4uC. Plates
were washed and blocked with PBS with 10% FBS for two hours
at room temperature. After washing, serial dilutions of culture
supernatants were added and incubated for two hours at room
temperature. Plates were washed again and alkaline phosphatase-
conjugated goat anti-mouse IgM was added and incubated for two
hours at room temperature. The reaction was developed with
Sigma 104 substrate (Sigma). Transcription factors expression was
analyzed on B cell subsets after 48 hour stimulation with CpG
1826.
Preparation of BM plasma
BM plasma was prepared by flushing femurs and tibias from
each mouse with 500 ml RPMI 1640 containing 0.5% BSA and
10 mM Hepes. After first centrifugation at 1500 rpm to collect
BM cells, debris were removed by repeated (26) centrifugation at
2,000 rpm for 10 min.
MIF quantification by ELISA
BM plasma and blood serum were assayed directly for MIF
content by a sandwich ELISA. Briefly, 96-well microtiter plates
(Greiner bio-one) were coated with the anti-mouse MIF mAb
(15 mg/ml in PBS), washed, and blocked with Superblock (Pierce).
Fifty-ml aliquots of each sample were added to wells and incubated
overnight at 4uC. The wells were washed and incubated with
rabbit polyclonal anti-MIF serum (1 mg/ml) for 2 h at room
temperature. This was followed by the addition of an anti-goat
IgG-HRP (Santa Cruz Biotechnology), and the antibody com-
plexes were quantified after the addition of TMB (3-39-5-59
tetrametilbenzidin) and H2O2 (R&D System). The MIF concen-
trations were calculated by extrapolation from a sigmoidal
quadratic standard curve using mouse rMIF.
Statistical analysis
Student’s paired t test was used to determine the significance of
differences between mean values. Data are reported as mean 6
SEM except where indicated. Values of P,0.05 were considered
significant.
Supporting Information
Figure S1 Unaltered BM lymphoid and myeloid lineage
representation in crt2/2/cd3e2/2 double KO FLC. (A) Statistical
analyses of the indicated subsets in the BM of crt+/+/cd3e2/2 and
crt2/2/cd3e2/2 FLC at week 12 from reconstitution. (B) Dot plot
analyses of BM cells from crt+/+/cd3e2/2 and crt2/2/cd3e2/2 FLC
stained with B220 and CD2, and statistical analysis of the pre-B
cell subset (below). (C) Dot plot analysis of electronically gated
B220+ BM cells stained with IgM and IgD antibodies and
histogram distribution of the indicated subsets (below), n = 4.
Found at: doi:10.1371/journal.pone.0011262.s001 (0.66 MB TIF)
Figure S2 Depletion of pre-B cells in the BM of crt2/2 FLC.
Statistical analysis of pre-B cells in the BM from FLC stained with
B220, CD43 and IgM specific antibodies.
Found at: doi:10.1371/journal.pone.0011262.s002 (0.10 MB TIF)
Figure S3 Reduction of BM mature B cells in IBD by ISO-1.
Statistical analysis of absolute numbers of mature (IgD+IgMlo/+ in
gated B220+ cells) B cells isolated from the BM of healthy controls
(Treg), mice with IBD either mock treated (IBD) or treated with
ISO-1 (IBD/ISO-1).
Found at: doi:10.1371/journal.pone.0011262.s003 (0.08 MB
TIF)
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